Results 271 to 280 of about 68,619 (285)

The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging

Cell Metabolism, 2016
Brian Keith Kennedy, Dudley Lamming
exaly  

Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex

Pediatric Neurology, 2020
Daniel Ebrahimi-Fakhari, Karen Agricola, Cynthia Tudor   +2 more
exaly  

Loss of the mechanistic target of rapamycin complexes 1 (mTORC1) causes a lethal alpha-1 antitrypsin deficiency associated liver disease

Zeitschrift für Gastroenterologie, 2023
Lisa Bewersdorf, Yizhao Luo, Annika Schmitz, Christian Preisinger, Thorsten Cramer, Pavel Strnad   +5 more
openaire   +1 more source

Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease

Circulation Research, 2014
Sebastiano Sciarretta, Massimo Volpe, Junichi Sadoshima   +2 more
exaly  

Mechanistic Target of Rapamycin (mTOR) in Tuberous Sclerosis Complex-Associated Epilepsy

Pediatric Neurology, 2015
Paolo Curatolo
exaly  

Rapamycin passes the torch: a new generation of mTOR inhibitors

Nature Reviews Drug Discovery, 2011
Marco Colombi, Christoph Moroni, Michael N Hall   +2 more
exaly  

Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases

Nature Reviews Rheumatology, 2015
Andras Perl
exaly  

Regulation of the mechanistic target of rapamycin complex 1 (mTORC1) - nuclear hormone receptor signaling by bile acids

Journal of Hepatology, 2017
T. Moustafa, A. Zaufel, T. Eichmann, D. Kolb-Lenz, M. Trauner, P. Fickert   +5 more
openaire   +1 more source

mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin

Science, 2013
Christopher L Cervantes, Daniel Lim, Nathanael S Gray   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly